NLRP3 and chronic obstructive pulmonary disease: Others have shown that TREM-1 inhibition with synthetic peptide LP17 ameliorates neuroinflammatory injury and chronic obstructive pulmonary disease (COPD) via NLRP3 inflammasome-mediated pyroptosis 37, 38.